DK0870500T3 - Anti-helicobacter polyri-middel - Google Patents
Anti-helicobacter polyri-middelInfo
- Publication number
- DK0870500T3 DK0870500T3 DK96942589T DK96942589T DK0870500T3 DK 0870500 T3 DK0870500 T3 DK 0870500T3 DK 96942589 T DK96942589 T DK 96942589T DK 96942589 T DK96942589 T DK 96942589T DK 0870500 T3 DK0870500 T3 DK 0870500T3
- Authority
- DK
- Denmark
- Prior art keywords
- helicobacter
- polyri
- agent
- cyclodextrin
- phenylüphenyl
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 abstract 2
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- 241000590002 Helicobacter pylori Species 0.000 abstract 1
- JBRMEFWJFBHUKG-LJGSYFOKSA-N NC(=N)NC[C@H]1CC[C@H](C(O)=O)CC1 Chemical compound NC(=N)NC[C@H]1CC[C@H](C(O)=O)CC1 JBRMEFWJFBHUKG-LJGSYFOKSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229940037467 helicobacter pylori Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Emergency Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Biological Depolymerization Polymers (AREA)
- Polyesters Or Polycarbonates (AREA)
- Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35466095 | 1995-12-22 | ||
| PCT/JP1996/003723 WO1997023207A1 (en) | 1995-12-22 | 1996-12-20 | Anti-helicobacter pylori agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0870500T3 true DK0870500T3 (da) | 2008-06-09 |
Family
ID=18439052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96942589T DK0870500T3 (da) | 1995-12-22 | 1996-12-20 | Anti-helicobacter polyri-middel |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20020123508A1 (da) |
| EP (1) | EP0870500B1 (da) |
| JP (1) | JP3468244B2 (da) |
| KR (1) | KR100332280B1 (da) |
| AT (1) | ATE386511T1 (da) |
| AU (2) | AU1171697A (da) |
| DE (1) | DE69637442T2 (da) |
| DK (1) | DK0870500T3 (da) |
| ES (1) | ES2301171T3 (da) |
| PT (1) | PT870500E (da) |
| TW (2) | TW457086B (da) |
| WO (1) | WO1997023207A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4658306B2 (ja) * | 2000-10-18 | 2011-03-23 | ナガセ医薬品株式会社 | 錠剤用医薬組成物 |
| US20080234182A1 (en) * | 2007-03-22 | 2008-09-25 | Innovative Biologics, Inc. | Blockers of pore-forming virulence factors and their use as anti-infectives |
| JP2007538112A (ja) * | 2004-01-29 | 2007-12-27 | ピナクル ファーマシューティカルズ | β−シクロデキストリン誘導体およびそれらの炭疽致死毒に対する使用 |
| US20070092502A1 (en) * | 2005-09-01 | 2007-04-26 | Allergan, Inc. | Method of Treating Glaucoma |
| PL2003130T3 (pl) | 2006-03-10 | 2012-04-30 | Link Genomics Inc | Nowa pochodna pirydyny o aktywności przeciwko helicobacter pylori |
| US8715731B2 (en) * | 2006-03-22 | 2014-05-06 | Isp Investments Inc. | Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin |
| BRPI1014314A2 (pt) | 2009-04-09 | 2019-09-24 | Arigen Pharmaceuticals Inc | derivado de tiopiridina, e, composição farmacêutica. |
| US12433853B2 (en) * | 2019-08-26 | 2025-10-07 | Kent State University | Rationally designed lawsone derivatives as antimicrobials against multidrug-resistant Staphylococcus aureus |
| TW202535382A (zh) * | 2023-11-29 | 2025-09-16 | 南韓商第一藥品股份有限公司 | 包含zastaprazan或其醫藥上可接受的鹽之用於幽門螺旋桿菌根除的組成物 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5692260A (en) | 1979-12-26 | 1981-07-25 | Nippon Chemiphar Co Ltd | Cyclohexanecarboxylic ester and its preparation |
| JPS5645454A (en) | 1979-09-20 | 1981-04-25 | Nippon Chemiphar Co Ltd | Cyclohexanecarboxylic acid derivative and its preparation |
| JPS5692261A (en) | 1979-12-26 | 1981-07-25 | Nippon Chemiphar Co Ltd | Novel cyclohexanecarboxylic derivative and its preparation |
| JPS5716855A (en) | 1980-07-04 | 1982-01-28 | Teikoku Chem Ind Corp Ltd | 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation |
| JPS5716856A (en) | 1980-07-04 | 1982-01-28 | Teikoku Chem Ind Corp Ltd | 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation |
| JPS5721360A (en) | 1980-07-14 | 1982-02-04 | Teikoku Chem Ind Corp Ltd | Allyl 4-guanidinomethylcyclohexanecarboxylate and its preparation |
| JPS5735556A (en) | 1980-08-08 | 1982-02-26 | Nippon Chemiphar Co Ltd | Preparation of guanidinomethylcyclohexanecarboxylic acid ester |
| JPS5748958A (en) | 1980-09-08 | 1982-03-20 | Nippon Chemiphar Co Ltd | Cyclohexanecarboxylic acid esters and their acid addition salts |
| JPS5748959A (en) | 1980-09-08 | 1982-03-20 | Nippon Chemiphar Co Ltd | Preparation of cyclohexanecarboxylic acid derivative or its salt |
| JPS5748960A (en) | 1980-09-08 | 1982-03-20 | Nippon Chemiphar Co Ltd | Novel cyclohexanecarboxylic acid derivative and its preparation |
| JPS5775922A (en) | 1980-10-29 | 1982-05-12 | Nippon Chemiphar Co Ltd | Novel remedy for peptic ulcer |
| JPS5775921A (en) | 1980-10-29 | 1982-05-12 | Nippon Chemiphar Co Ltd | Noval remedy for peptic ulcer |
| JPS5775920A (en) | 1980-10-29 | 1982-05-12 | Nippon Chemiphar Co Ltd | Noval remedy for peptic ulcer |
| JPS57122059A (en) | 1981-01-22 | 1982-07-29 | Nippon Chemiphar Co Ltd | Novel cyclohexanecarboxylic acid derivative and its preparation |
| JPS57122062A (en) | 1981-01-22 | 1982-07-29 | Nippon Chemiphar Co Ltd | Novel trans-4-guanidinocyclohexanecarboxylic acid derivative and its preparation |
| JPS57126463A (en) | 1981-01-29 | 1982-08-06 | Nippon Chemiphar Co Ltd | Novel carboxylic ester and its preparation |
| JPS57122060A (en) | 1981-01-22 | 1982-07-29 | Nippon Chemiphar Co Ltd | Carboxylic acid ester and its preparation |
| JPS57122061A (en) | 1981-01-22 | 1982-07-29 | Nippon Chemiphar Co Ltd | Novel cyclohexanecarboxylic acid derivative and its preparation |
| JPS57126462A (en) | 1981-01-29 | 1982-08-06 | Nippon Chemiphar Co Ltd | Novel carboxylic ester and its preparation |
| JPS57126461A (en) | 1981-01-29 | 1982-08-06 | Nippon Chemiphar Co Ltd | Novel guanidino compound and its preparation |
| JPS5838250A (ja) * | 1981-09-01 | 1983-03-05 | Teikoku Chem Ind Corp Ltd | 複合体 |
| JPS6254A (ja) | 1985-03-08 | 1987-01-06 | Kanebo Ltd | 新規グアニジノメチルシクロヘキサンカルボン酸誘導体および該化合物を有効成分とする抗潰瘍薬 |
| JPS6330462A (ja) | 1986-07-24 | 1988-02-09 | Taiyo Yakuhin Kogyo Kk | 新規グアニジノメチルベンツアミド誘導体およびそれを有効成分とする抗潰瘍剤 |
| JPS63218652A (ja) | 1987-03-09 | 1988-09-12 | Taiyo Yakuhin Kogyo Kk | 新規グアニジノメチル安息香酸誘導体およびこれを含有する消化性潰瘍治療剤 |
| JPH04217950A (ja) | 1990-03-28 | 1992-08-07 | Asahi Chem Ind Co Ltd | ヒドロキサム酸誘導体および酵素阻害剤ならびに抗潰瘍剤 |
| JP3073006B2 (ja) | 1990-11-28 | 2000-08-07 | 株式会社日立製作所 | 聴覚機能補助装置 |
| AU4993893A (en) * | 1992-07-31 | 1994-03-03 | Neose Pharmaceuticals, Inc. | Compositions for treating and inhibiting gastric and duodenal ulcers |
| JP3150781B2 (ja) | 1992-09-01 | 2001-03-26 | 株式会社資生堂 | 皮膚外用剤 |
| JP3150780B2 (ja) | 1992-09-01 | 2001-03-26 | 株式会社資生堂 | 皮膚外用剤 |
| DE69316681T2 (de) | 1992-08-27 | 1998-05-14 | Shiseido Co Ltd | Äusserliche, auf der Haut anzuwendende Depigmentierungsmittel enthaltende Zusammensetzung |
| JP3150782B2 (ja) | 1992-09-01 | 2001-03-26 | 株式会社資生堂 | 皮膚外用剤 |
| GB9221707D0 (en) * | 1992-10-15 | 1992-12-02 | Smithkline Beecham Plc | Pharmaceutical composition |
| DE4339134A1 (de) * | 1993-11-16 | 1995-05-18 | Bayer Ag | 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate |
| JP3796612B2 (ja) * | 1994-02-18 | 2006-07-12 | ナガセケムテックス株式会社 | 抗菌剤 |
| AUPM456894A0 (en) * | 1994-03-18 | 1994-04-14 | Glyzinc Pharmaceuticals Limited | Treatment for gastric disorders |
| WO1996006825A1 (en) * | 1994-08-30 | 1996-03-07 | Teikoku Chemical Industries Co., Ltd. | Guanidinomethyl cyclohexane carboxylic ester derivative |
| JP3046288B1 (ja) | 1998-12-28 | 2000-05-29 | 京セラ株式会社 | 半導体・液晶製造装置用部材 |
-
1996
- 1996-12-20 DE DE69637442T patent/DE69637442T2/de not_active Expired - Fee Related
- 1996-12-20 AT AT96942589T patent/ATE386511T1/de not_active IP Right Cessation
- 1996-12-20 PT PT96942589T patent/PT870500E/pt unknown
- 1996-12-20 US US09/091,588 patent/US20020123508A1/en active Granted
- 1996-12-20 US US09/091,588 patent/US6444703B1/en not_active Expired - Fee Related
- 1996-12-20 EP EP96942589A patent/EP0870500B1/en not_active Expired - Lifetime
- 1996-12-20 WO PCT/JP1996/003723 patent/WO1997023207A1/ja not_active Ceased
- 1996-12-20 KR KR1019980704583A patent/KR100332280B1/ko not_active Expired - Fee Related
- 1996-12-20 DK DK96942589T patent/DK0870500T3/da active
- 1996-12-20 JP JP52350197A patent/JP3468244B2/ja not_active Expired - Fee Related
- 1996-12-20 AU AU11716/97A patent/AU1171697A/en not_active Abandoned
- 1996-12-20 ES ES96942589T patent/ES2301171T3/es not_active Expired - Lifetime
-
1997
- 1997-01-20 TW TW085115861A patent/TW457086B/zh not_active IP Right Cessation
- 1997-01-20 TW TW090111426A patent/TWI225786B/zh not_active IP Right Cessation
-
2001
- 2001-02-12 AU AU19709/01A patent/AU763893C/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| PT870500E (pt) | 2008-05-07 |
| US6444703B1 (en) | 2002-09-03 |
| TWI225786B (en) | 2005-01-01 |
| ATE386511T1 (de) | 2008-03-15 |
| TW457086B (en) | 2001-10-01 |
| US20020123508A1 (en) | 2002-09-05 |
| ES2301171T3 (es) | 2008-06-16 |
| AU763893B2 (en) | 2003-07-31 |
| DE69637442D1 (de) | 2008-04-03 |
| AU763893C (en) | 2004-06-03 |
| EP0870500A4 (en) | 2001-09-12 |
| DE69637442T2 (de) | 2008-05-21 |
| KR19990072207A (ko) | 1999-09-27 |
| AU1970901A (en) | 2001-04-26 |
| EP0870500A1 (en) | 1998-10-14 |
| KR100332280B1 (ko) | 2002-06-20 |
| WO1997023207A1 (en) | 1997-07-03 |
| JP3468244B2 (ja) | 2003-11-17 |
| AU1171697A (en) | 1997-07-17 |
| EP0870500B1 (en) | 2008-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO974572D0 (no) | Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav | |
| DE69610751D1 (de) | Elektronenemittierende Vorrichtung, Elektronenquelle und damit versehenes Bilderzeugungsgerät sowie Verfahren zu deren Herstellung | |
| WO1989012624A3 (en) | Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom | |
| AU687903B2 (en) | Pharmaceutical composition containg a diclofanac salt and 2-hydroxypropyl-beta-cyclodextrin | |
| DE69526428D1 (de) | Verfahren zur erhöhung der bioverfügbarkeit oraler arzneimittel | |
| FI945839L (fi) | Bentsotiofeeniyhdisteiden ja vesiliukoisten syklodekstriinien inkluusiokompleksien vesipitoinen liuos ja niiden farmaseuttiset formulaatiot sekä menetelmä | |
| PT870500E (pt) | Agente anti-helicobacter pylori | |
| ITBO920452A0 (it) | "metodo per la realizzazione di protesi da implantologia e dispositivoper l'attuazione di tale metodo". | |
| ATE433325T1 (de) | Multimerer, rekombinanter urease impfstoff | |
| ES2192245T3 (es) | Emplastos que contienen principios activos. | |
| FI103860B1 (fi) | Glutaarialdehydiä ja 1,2-bentsisotiatsolin-3-onia sisältävä, vesipitoinen biosidinen koostumus ja menetelmä vesipohjaisen koostumuksen suojaamiseksi biologiselta kontaminaatiolta | |
| FI955793A7 (fi) | Menetelmä biohajoavan, hydrofobisen ja läpinäkyvän kalvon valmistamise ksi ja näin saatu kalvo | |
| DE3773077D1 (de) | Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DK0378303T3 (da) | Undertrykkelse af mercaptanluft fra organothiophosphatbiocider | |
| AU6580494A (en) | Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases | |
| FI973105L (fi) | Menetelmä (4,10-diasetoksi-2alfa-bentsoyylioksi-5beta,20-epoksi,1,7beta-dihydroksi-9-oksotaks-11-en-13alfa-yyli)-(2R,3S)-3-bentsoyyliamino-3-fenyyli-2-hydroksipropionaattitrihydraatin valmistamiseksi | |
| ES2045154T3 (es) | Procedimiento mejorado de precipitacion de vancomicina. | |
| AU6701998A (en) | Method for treatment of (h. pylori) | |
| FI951655L (fi) | H.pylori -infektioiden hoito | |
| ITTO930410A0 (it) | Procedimento e impianto per la trasformazione di rifiuti. | |
| AU6134896A (en) | Resolution of 1-azabicyclo{2.2.2}octan-3-amine, 2-(diphenylmethyl)-n -{{2-methoxy-5-(1-methylethyl)phenyl}methyl} | |
| PT1121100E (pt) | Processo de preparacao de uma solucao para pulverizacao nasal que contem uma ou mais hormonas sexuais e uma ciclodextrina | |
| TR199901165A3 (tr) | Piretroid bilesimi ve salgin hastaliklari için bunu içeren bilesikler. | |
| ATE232361T1 (de) | Pestizide formulierungen und verfahren zur deren herstellung | |
| CA2486571A1 (en) | Pharmaceutical composition |